Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate and postoperative neurocognitive function in elderly orthopedic surgery
ChiCTR2300078594Phase 3Recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium oxybate in Postoperative neurocognitive disorder (PND), postoperative delirium (POD), postoperative pain and 1 more (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Confusion Assessment Method for the ICU (CAM-ICU) and Visual analogue scale for pain. Started Dec 2023; status: recruiting.
02
Drugs
sodium oxybate
03
Conditions
Postoperative neurocognitive disorder (PND)postoperative delirium (POD)postoperative painInsomnia
Beyond the preview
Go deeper on ChiCTR2300078594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078594.